Projected long‐term outcomes in patients with type 1 diabetes treated with fast‐acting insulin aspart vs conventional insulin aspart in the UK setting

AIM: To assess the impact of faster aspart vs insulin aspart on long‐term clinical outcomes and costs for patients with type 1 diabetes mellitus (T1DM) in the UK setting. METHODS: The QuintilesIMS CORE Diabetes Model was used to project clinical outcomes and costs over patient lifetimes in a cohort...

Descripción completa

Detalles Bibliográficos
Autores principales: Russell‐Jones, David, Heller, Simon R., Buchs, Sarah, Sandberg, Anna, Valentine, William J., Hunt, Barnaby
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5697732/
https://www.ncbi.nlm.nih.gov/pubmed/28573681
http://dx.doi.org/10.1111/dom.13026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5697732/
https://www.ncbi.nlm.nih.gov/pubmed/28573681
http://dx.doi.org/10.1111/dom.13026

Ejemplares similares